Leigh encephalopathy: histologic and biochemical analyses of muscle biopsies.
To elucidate the pathogenesis of Leigh encephalopathy, histologic, biochemical, and mitochondrial DNA analyses were performed on biopsied muscles from 33 patients with the clinical characteristics of this disorder. On muscle histochemistry, cytochrome c oxidase activity was decreased or absent in 7 patients (21%), although none had ragged-red fibers. In 2 patients with cytochrome c oxidase deficiency, staining for this enzyme was poor in the muscle fibers and fibroblasts but was normal in the arterial wall, indicating tissue-specific involvement. Ten patients (30%) had biochemical defects, including 2 with pyruvate dehydrogenase complex, 4 with cytochrome c oxidase, 1 with NADH-cytochrome c reductase (complex I), and 3 with multiple complex deficiencies. None of the 28 patients in whom muscle mitochondrial (mt)DNA was analyzed had DNA deletions or point mutation at nucleotide positions 3,243 or 8,344. These results indicate that the underlying defect in Leigh encephalopathy is heterogeneous because only 30% of patients had enzyme defects demonstrable in muscle biopsy material.
Nagai
T
T
Division of Ultrastructural Research, National Institute of Neuroscience, Tokyo, Japan.
Goto
Y
Y
Matsuoka
T
T
Sakuta
R
R
Naito
E
E
Kuroda
Y
Y
Nonaka
I
I
D002648:Child; D002675:Child, Preschool; D002872:Chromosome Deletion; D030401:Cytochrome-c Oxidase Deficiency; D004272:DNA, Mitochondrial / Q000235:genetics; D003937:Diagnosis, Differential; D004798:Enzymes / Q000172:deficiency*; D005260:Female; D006801:Humans; D007223:Infant; D007888:Leigh Disease / Q000201:enzymology / Q000235:genetics / Q000473:pathology*; D017241:MELAS Syndrome / Q000201:enzymology / Q000235:genetics / Q000473:pathology; D017243:MERRF Syndrome / Q000201:enzymology / Q000235:genetics / Q000473:pathology; D008297:Male; D009131:Muscle, Smooth, Vascular / Q000201:enzymology / Q000473:pathology; D009132:Muscles / Q000201:enzymology / Q000473:pathology*; D009245:NADH Dehydrogenase / Q000172:deficiency; D017354:Point Mutation; D015324:Pyruvate Carboxylase Deficiency Disease / Q000201:enzymology / Q000235:genetics / Q000473:pathology; D015325:Pyruvate Dehydrogenase Complex Deficiency Disease / Q000201:enzymology / Q000235:genetics / Q000473:pathology
D004272:DNA, Mitochondrial; D004798:Enzymes; D009245:NADH Dehydrogenase